StockData
Cardiff Oncology, Inc. logo

Cardiff Oncology, Inc. (CRDF) KPIs and segments

CRDFNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$0.85−0.04 (-4.46%)

Close on Nov 20, 2026Market cap $66.34MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Cardiff Oncology's business

Coming soon

This tab will track the numbers specific to Cardiff Oncology's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?